RhumbLine Advisers’s Milestone Scientific MLSS Stock Holding History

RhumbLine Advisers’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27,166	Closed	-$97K	–	3065
2021 Q1	$97K	Sell	27,166 -1,940	-7%	-$6.65K	﹤0.01%	2936
2020 Q4	$62K	Buy	29,106 +5,302	+22%	+$9.34K	﹤0.01%	3014
2020 Q3	$33K	Sell	23,804 -4,965	-17%	-$8.66K	﹤0.01%	2962
2020 Q2	$56K	Buy	+28,769	New	+$52.7K	﹤0.01%	3024

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RhumbLine Advisers's MLSS Position: Q2 2021 in Review

RhumbLine Advisers sold out of Milestone Scientific (MLSS) in Q2 2021, closing a stake of 27,166 shares — an estimated $97K sold.

RhumbLine Advisers first reported a position in MLSS in Q2 2020 and held it in 4 quarters. The position peaked at $97K in Q1 2021. 45 funds tracked by Wall St. Rank hold MLSS as of Q2 2021.

RhumbLine Advisers reported no remaining Milestone Scientific position as of Q2 2021 after selling out during the quarter.
RhumbLine Advisers sold 27,166 Milestone Scientific shares in Q2 2021, an estimated $97K.
RhumbLine Advisers first reported a position in Milestone Scientific in Q2 2020 and held it in 4 quarters.
RhumbLine Advisers's Milestone Scientific position peaked at $97K in Q1 2021.
45 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.